Keywords: ایمنی ضد تومور; Anti-tumor immunity; Immune suppression; Immune memory; Drug development; Anti-cancer drug scheduling; DC; dendritic cell; ICD; immunogenic cell death; IFN; interferon; MEDIC; medium-dose intermittent chemotherapy; MTD; maximum tolerated dose; NK; natural
مقالات ISI ایمنی ضد تومور (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمنی ضد تومور; Radiotherapy; Immunotherapy; Anti-tumor immunity; Abscopal effect; Immunogenic cell death; Radiothérapie; Immunothérapie; Immunité anti tumorale; Effet abscopal; Mort cellulaire immunogène;
Keywords: ایمنی ضد تومور; Cancer immunotherapy; Anti-tumor immunity; Tumor-immune escape;
Keywords: ایمنی ضد تومور; Cancer immunogenic cell death; ICD inducers; Anti-tumor immunity;
Keywords: ایمنی ضد تومور; High-intensity focused ultrasound; Thermal ablation; Anti-tumor immunity; Tumor vaccine; Radiation therapy; Cancer; Immuno-therapy;
Keywords: ایمنی ضد تومور; MSCs; SMG; Anti-tumor immunity; Vaccination; CTL;
Keywords: ایمنی ضد تومور; Triple-negative breast cancer; Anti-tumor immunity; Immunotherapy; Immune checkpoints; Cancer treatment;
Keywords: ایمنی ضد تومور; Anti-tumor immunity; Sex; Alcohol; Dendritic cell; Cytotoxic T cell;
Keywords: ایمنی ضد تومور; Mechanisms of metronomic chemotherapy; Angiogenesis; Therapeutic resistance; MTDL alternative; Anti-tumor immunity;
Keywords: ایمنی ضد تومور; Interleukin-27; IL-27p28; Inflammation; Virus infection; Anti-tumor immunity
Keywords: ایمنی ضد تومور; Gy; gray; Ab; antibody; TGF-β; transforming growth factor-β; TNF; tumor necrosis factor; SASP; senescence-associated secretory phenotype; MCP-1; monocyte chemoattractant protein-1; MHC; major histocompatibility complex; DAMP; damage-associated molecular
Keywords: ایمنی ضد تومور; Anti-Tumor Immunity; Viral Infection; Survival; Stomach Cancer; APO; apolipoprotein; CIITA; class II major histocompatibility complex trans activator gene; CXCL; CXC motif ligand; CXCR; CXC motif chemokine receptors; DEG; differentially expressed gene; EB
Keywords: ایمنی ضد تومور; Mevalonate pathway; Statins; Cancer; Anti-tumor immunity; Adjuvant therapy
Vaccination with FasL-/TCL plus MHSP65 induces improved anti-lung cancer immunity in mice
Keywords: ایمنی ضد تومور; Tumor cell lysate; Mouse splenocytes; Apoptosis; Lung cancer; Anti-tumor immunity; FasL;
Soluble PD-1-based vaccine targeting MUC1 VNTR and survivin improves anti-tumor effect
Keywords: ایمنی ضد تومور; Soluble PD-1; Cancer vaccine; MUC1; Survivin; Anti-tumor immunity;
Nitrated T helper cell epitopes enhance the immunogenicity of HER2 vaccine and induce anti-tumor immunity
Keywords: ایمنی ضد تومور; Human epidermal growth factor receptor 2; Universal T cell epitope; Anti-tumor immunity; Nitration; CTL; cytotoxic T lymphocyte; E:T; effector:target; HER2; Human epidermal growth factor receptor 2; LDH; lactate dehydrogenase; MHC; Major histocompatibilit
Photochemical delivery of bleomycin induces T-cell activation of importance for curative effect and systemic anti-tumor immunity
Keywords: ایمنی ضد تومور; Photochemical internalization; Photodynamic; Bleomycin; Anti-tumor immunity;
Density of tumor-infiltrating granzyme B-positive cells predicts favorable prognosis in dogs with transitional cell carcinoma
Keywords: ایمنی ضد تومور; Canine; Urothelial carcinoma; Urinary bladder; Tumor-infiltrating lymphocytes; Anti-tumor immunity;
Telltale tumor infiltrating lymphocytes (TIL) in oral, head & neck cancer
Keywords: ایمنی ضد تومور; Tumor-infiltrating lymphocytes (TIL); Innate immunity; Oral cancer; Head and neck cancer; Type 1 interferon; Autophagy; Immunogenicity; Prognosis; Anti-tumor immunity; Immunotherapy;
l-arginine and docetaxel synergistically enhance anti-tumor immunity by modifying the immune status of tumor-bearing mice
Keywords: ایمنی ضد تومور; Breast cancer; l-arginine; Docetaxel; Anti-tumor immunity
Ubiquitin-specific Protease-7 Inhibition Impairs Tip60-dependent Foxp3Â + T-regulatory Cell Function and Promotes Antitumor Immunity
Keywords: ایمنی ضد تومور; Immuno-oncology; Anti-tumor immunity; T-regulatory cells; Deubiquitination;
Caffeine promotes anti-tumor immune response during tumor initiation: Involvement of the adenosine A2A receptor
Keywords: ایمنی ضد تومور; Adenosine; A2AR; Caffeine; 3-MCA; Anti-tumor immunity
Dichotomous role of protein kinase A type I (PKAI) in the tumor microenvironment: A potential target for 'two-in-one' cancer chemoimmunotherapeutics
Keywords: ایمنی ضد تومور; Anti-tumor immunity; AS-PKAI; Chemoimmunotherapeutics; Immunosurveillance; 'Two-in-one'; Tumor reversion; 3LL; Lewis lung carcinoma; AC; adenylyl cyclase; AS-PKAI; antisense oligonucleotide targeted against RI/PKAI; ATP; adenosine-5'-triphosphate; bFG
Comparative effect of two pan-class I PI3K inhibitors used as anticancer drugs on human T cell function
Keywords: ایمنی ضد تومور; Cancer therapy; PI3K inhibitor; Anti-tumor immunity; T cell
Non-Structural protein 1 (NS1) gene of Canine Parvovirus-2 regresses chemically induced skin tumors in Wistar rats
Keywords: ایمنی ضد تومور; Canine Parvovirus-2 NS1 gene; Viral gene oncotherapy; DMBA; Squamous cell carcinoma; Tumor regression; Anti-tumor immunity
EWS/FLI-l peptide-pulsed dendritic cells induces the antitumor immunity in a murine Ewing's sarcoma cell model
Keywords: ایمنی ضد تومور; EWS/FLI-l; Dendritic cells; Anti-tumor immunity; Ewing's sarcoma;
Immunomodulatory effect of poly-γ-glutamic acid derived from Bacillus subtilis on natural killer dendritic cells
Keywords: ایمنی ضد تومور; γPGA; NKDC; IL12; IFNγ; TNFα; Anti-tumor immunity;
Interfering with coinhibitory molecules: BTLA/HVEM as new targets to enhance anti-tumor immunity
Keywords: ایمنی ضد تومور; PD1; BTLA; HVEM; Anti-tumor immunity; Co-inhibitory molecules; Cosignaling; BTLA; B- and T-lymphocyte attenuator; CTLA-4; CTL-associated-antigen-4; CRD; cystein-rich domain; HVEM; herpes virus entry mediator; Ig; immunoglobulin; LIGHT; homologous to lymph
Re-evaluation of the involvement of NK cells and C-type lectin-like NK receptors in modulation of immune responses by multivalent GlcNAc-terminated oligosaccharides
Keywords: ایمنی ضد تومور; Clr; C-type lectin related protein; GlcNAc; N-acetyl-d-glucosamine; GN4P: GlcNAc4-PAMAM; N-acetyl-d-glucosamine-coated tetrabranched polyamidoamine dendrimer; GN8P: GlcNAc8-PAMAM; N-acetyl-d-glucosamine-coated octabranched polyamidoamine dendrimer; GN4P-A
Systemically administered gp100 encoding DNA vaccine for melanoma using water-in-oil-in-water multiple emulsion delivery systems
Keywords: ایمنی ضد تومور; Anti-tumor immunity; W/O/W multiple emulsions; gp100 encoding plasmid DNA; Melanoma; Vaccine
Resveratrol analog, HS-1793 enhance anti-tumor immunity by reducing the CD4+CD25 + regulatory T cells in FM3A tumor bearing mice
Keywords: ایمنی ضد تومور; Resveratrol analog; HS-1793; Treg cell; Cytotoxic T lymphocyte; Anti-tumor immunity; FM3A cell
Interleukin-17A is involved in enhancement of tumor progression in murine intestine
Keywords: ایمنی ضد تومور; Apc; adenomatous polyposis coili; i.c.; inoculation into subserosa of cecum; IFN; interferon; IL; interleukin; KO; gene knock-out; mAb; monoclonal antibody; MLN; mesenteric lymph node; r; recombinant; s.c.; subcutaneous; Anti-tumor immunity; Interleukin-1
Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells
Keywords: ایمنی ضد تومور; DC-SIGN; Antigen-targeting; Glycans; Anti-tumor immunity; CD4 T-cells; CD8 T-cells
MF59 formulated with CpG ODN as a potent adjuvant of recombinant HSP65-MUC1 for inducing anti-MUC1+ tumor immunity in mice
Keywords: ایمنی ضد تومور; Adjuvant; MF59; CpG oligodeoxynucleotides (ODN); Melanoma; Anti-tumor immunity
Virosome: A novel vector to enable multi-modal strategies for cancer therapy
Keywords: ایمنی ضد تومور; Pseudovirion; Synthetic vector; Virus; Anti-tumor immunity; Apoptosis; RNA; Fusion protein
Galectin-9 signaling prolongs survival in murine lung-cancer by inducing macrophages to differentiate into plasmacytoid dendritic cell-like macrophages
Keywords: ایمنی ضد تومور; Galectin-9; M-CSF; pDC-like Mϕ; NK cell; Anti-tumor immunity
CD4 T cell dependent tumor immunity stimulated by dendritic cell based vaccine
Keywords: ایمنی ضد تومور; Anti-tumor immunity; CD4 T cells; Vaccination; IL-12; CD40;
Dendritic cells stimulated with outer membrane protein A (OmpA) of Salmonella typhimurium generate effective anti-tumor immunity
Keywords: ایمنی ضد تومور; Dendritic cells; Outer membrane protein A; Anti-tumor immunity
The complete preventive effect of homologous tumor vaccines – Based on a 5-year experimental study in mice
Keywords: ایمنی ضد تومور; Tumor vaccine; Mice; Anti-tumor immunity; Preventive effect
DNA vaccine with α-galactosylceramide at prime phase enhances anti-tumor immunity after boosting with antigen-expressing dendritic cells
Keywords: ایمنی ضد تومور; DNA vaccine; α-Galactosylceramide; Anti-tumor immunity
Human uveal melanoma cells inhibit the immunostimulatory function of dendritic cells
Keywords: ایمنی ضد تومور; uveal melanoma; dendritic cell; anti-tumor immunity; immunotherapy
4-1BB-mediated expansion affords superior detection of in vivo primed effector memory CD8+ T cells from melanoma sentinel lymph nodes
Keywords: ایمنی ضد تومور; SLN, sentinel lymph node; DTH, delayed type hypersensitivity; aAPC, artificial antigen presenting cell; TAA, tumor-associated antigenArtificial APC; T cell monitoring; Anti-tumor immunity; Tumor-associated antigens; T cell expansion
Targeting anti-tumor DNA vaccines to dendritic cells via a short CD11c promoter sequence
Keywords: ایمنی ضد تومور; CD11c promoter; DNA vaccine; Anti-tumor immunity
Salmonella type III-mediated heterologous antigen delivery: A versatile oral vaccination strategy to induce cellular immunity against infectious agents and tumors
Keywords: ایمنی ضد تومور; Salmonella T3SS; Sequential translocation; Memory CD8 T cells; Anti-tumor immunity
The effect of high intensity focused ultrasound treatment on metastases in a murine melanoma model
Keywords: ایمنی ضد تومور; High intensity focused ultrasound; Metastasis; Anti-tumor immunity; Bioluminescent imaging; Melanoma
Modification of CEA with both CRT and TAT PTD induces potent anti-tumor immune responses in RNA-pulsed DC vaccination
Keywords: ایمنی ضد تومور; Calreticulin; HIV TAT; Dendritic cells; Carcinoembryonic antigen; Anti-tumor immunity
Two oral HBx vaccines delivered by live attenuated Salmonella: Both eliciting effective anti-tumor immunity
Keywords: ایمنی ضد تومور; Tumor vaccine; Salmonella; Type III secretion system (TTSS); Hepatitis B virus x gene (HBx); Anti-tumor immunity
Direct vaccination with pseudotype baculovirus expressing murine telomerase induces anti-tumor immunity comparable with RNA-electroporated dendritic cells in a murine glioma model
Keywords: ایمنی ضد تومور; Pseudotype baculovirus; VSV G; Gene therapy; Glioma; Cytotoxic T cells; Anti-tumor immunity
Inhibitory costimulation and anti-tumor immunity
Keywords: ایمنی ضد تومور; Costimulation; B7; Anti-tumor immunity; Tolerance
Vaccination with IFN-inducible T cell α chemoattractant (ITAC) gene-modified tumor cell attenuates disseminated metastases of circulating tumor cells
Keywords: ایمنی ضد تومور; ITAC; Anti-tumor immunity; 4T1